If you are interested in participating in the following trial, please contact the relevant Trial Chairperson or Trial Centre Data Manager.

TROG 03.07 - A Randomised Phase II Study of Two Regimens of Palliative Chemoradiation Therapy in the Management of Locally Advanced Non Small Cell Lung Cancer.

Date first patient entered: 4 December 2003

Target Accrual: 80

Hypotheses: Vinorelbine + cisplatin + high-dose palliative radiotherapy is superior to gemcitabine + high dose palliative radiotherapy in terms of efficacy in a multi-institutional setting.
Vinorelbine + cisplatin + high-dose palliative radiotherapy is superior to gemcitabine + high dose palliative radiotherapy in terms of feasibility in a multi-institutional setting.
Vinorelbine + cisplatin + high-dose palliative radiotherapy has a favourable toxicity profile relative to gemcitabine + high-dose palliative radiotherapy.

Trial Contacts:
Trial Chairpersons
Associate Professor Bryan Burmeister
Princess Alexandra Hospital
Ipswich Road
Woolloongabba QLD 4102
Fax: +61 7 3240 2670

Dr Michael Michael
Peter MacCallum Cancer Centre
St Andrews Place
East Melbourne VIC 3002
Fax: +61 3 9565 1424

Trial Centre Data Manager
Ms Sharon Cox
Clinical Trial Coordinator
Oncology Haematology Radiation Research Unit
Princess Alexandra Hospital, Ipswich Rd, Woolloongabba QLD 4102
Fax: +61 7 3240 2252

More Information

[ Open Trials - Home ]